Zunhui Du MS , Yanting Zhou MS , Qiheng Li MS , Yuan Xie MS , Tingfang Zhu MS , Jing Qiao MS , Ruihong Zhang BS , Yangyang Bao MD, PhD , Lingjie Wang MD, PhD , Yinyin Xie PhD , Jinwei Quan MS , Menglu Lin MS , Ning Zhang MD, PhD , Qi Jin MD, PhD , Wenbin Liang MD, PhD , Liqun Wu MD, PhD , Tong Yin MD, PhD , Yucai Xie MD, PhD
{"title":"SIRT1 Ameliorates Lamin A/C Deficiency-Induced Cardiac Dysfunction by Promoting Mitochondrial Bioenergetics","authors":"Zunhui Du MS , Yanting Zhou MS , Qiheng Li MS , Yuan Xie MS , Tingfang Zhu MS , Jing Qiao MS , Ruihong Zhang BS , Yangyang Bao MD, PhD , Lingjie Wang MD, PhD , Yinyin Xie PhD , Jinwei Quan MS , Menglu Lin MS , Ning Zhang MD, PhD , Qi Jin MD, PhD , Wenbin Liang MD, PhD , Liqun Wu MD, PhD , Tong Yin MD, PhD , Yucai Xie MD, PhD","doi":"10.1016/j.jacbts.2024.05.011","DOIUrl":null,"url":null,"abstract":"<div><div>Dilated cardiomyopathy (DCM) is associated with high mortality despite advanced therapies. The <em>LMNA</em> gene encodes lamin A/C and is the second most frequently mutated gene associated with DCM, for which therapeutic options are limited. Here we generated <em>Lmna</em><sup>–/–</sup> mice and found they exhibited cardiac dysfunction at the age of 1 month but not at 2 weeks. Proteomics showed down-regulation of mitochondrial function–related pathways in <em>Lmna</em><sup>–/–</sup> hearts. Moreover, early injured mitochondria with decreased cristae density and sirtuin 1 (SIRT1) down-regulation were observed in 2-week-old <em>Lmna</em><sup>–/–</sup> hearts. Adenoviral overexpression of SIRT1 in lamin A/C knockdown neonatal rat ventricular myocytes improved mitochondrial oxidative respiration capacity. Adeno-associated virus–mediated SIRT1 overexpression alleviated mitochondrial injury, cardiac systolic dysfunction, ventricular dilation, and fibrosis, and prolonged lifespan in <em>Lmna</em><sup>–/–</sup> mice. Mechanistically, <em>LMNA</em> maintains mitochondrial bioenergetics through the SIRT1-PARKIN axis. Our results suggest that targeting the SIRT1 signaling pathway is expected to be a novel therapeutic strategy for <em>LMNA</em> mutation–associated DCM.</div></div>","PeriodicalId":14831,"journal":{"name":"JACC: Basic to Translational Science","volume":"9 10","pages":"Pages 1211-1230"},"PeriodicalIF":8.4000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC: Basic to Translational Science","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2452302X24002183","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Dilated cardiomyopathy (DCM) is associated with high mortality despite advanced therapies. The LMNA gene encodes lamin A/C and is the second most frequently mutated gene associated with DCM, for which therapeutic options are limited. Here we generated Lmna–/– mice and found they exhibited cardiac dysfunction at the age of 1 month but not at 2 weeks. Proteomics showed down-regulation of mitochondrial function–related pathways in Lmna–/– hearts. Moreover, early injured mitochondria with decreased cristae density and sirtuin 1 (SIRT1) down-regulation were observed in 2-week-old Lmna–/– hearts. Adenoviral overexpression of SIRT1 in lamin A/C knockdown neonatal rat ventricular myocytes improved mitochondrial oxidative respiration capacity. Adeno-associated virus–mediated SIRT1 overexpression alleviated mitochondrial injury, cardiac systolic dysfunction, ventricular dilation, and fibrosis, and prolonged lifespan in Lmna–/– mice. Mechanistically, LMNA maintains mitochondrial bioenergetics through the SIRT1-PARKIN axis. Our results suggest that targeting the SIRT1 signaling pathway is expected to be a novel therapeutic strategy for LMNA mutation–associated DCM.
期刊介绍:
JACC: Basic to Translational Science is an open access journal that is part of the renowned Journal of the American College of Cardiology (JACC). It focuses on advancing the field of Translational Cardiovascular Medicine and aims to accelerate the translation of new scientific discoveries into therapies that improve outcomes for patients with or at risk for Cardiovascular Disease. The journal covers thematic areas such as pre-clinical research, clinical trials, personalized medicine, novel drugs, devices, and biologics, proteomics, genomics, and metabolomics, as well as early phase clinical trial methodology.